BamSEC and AlphaSense Join Forces
Learn More

Tevogen Bio Holdings Inc.

NASDAQ: TVGN    
Share price (12/23/24): $1.01    
Market cap (12/23/24): $177 million

Material Contracts Filter

EX-10.1
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 5 pages Preferred Stock Repurchase Agreement
12/34/56
EX-10.15
from 10-K 5 pages Securities Purchase Agreement
12/34/56
EX-10.14
from 10-K 8 pages Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan Restricted Stock Unit Agreement Cover Sheet
12/34/56
EX-10.13
from 10-K 2 pages Amendment to Assignment and Assumption Agreement
12/34/56
EX-10.8
from 10-K 8 pages Non-Competition and Non-Solicitation Agreement
12/34/56
EX-10.7
from 10-K 16 pages Lock-Up Agreement
12/34/56
EX-10.6
from 10-K 29 pages Amended and Restated Registration Rights Agreement
12/34/56
EX-10.5
from 10-K 4 pages February 13, 2024 Confidential Semper Paratus Acquisition Corporation 767 Third Avenue, 38th Floor New York, New York 10017 Re: Amendment to Letter Agreement, Dated November 3, 2021 1. Amendments
12/34/56
EX-10.1
from 8-K 5 pages Amended and Restated Securities Purchase Agreement
12/34/56
EX-10.11
from 8-K/A 3 pages Assignment and Assumption Agreement
12/34/56
EX-10.10
from 8-K 18 pages Indemnification Agreement
12/34/56
EX-10.9
from 8-K 7 pages Tevogen Bio Inc. 2024 Omnibus Incentive Plan Restricted Stock Unit Agreement Cover Sheet
12/34/56
EX-10.8
from 8-K 37 pages Page 1. Purpose 1 2. Definitions 1 3. Administration of the Plan 9 3.1 Committee. 9 3.1.1 Powers and Authorities. 9 3.1.2 Composition of the Committee. 9 3.1.3 Other Committees. 10 3.1.4 Delegation by the Committee. 10 3.2 Board. 10 3.3 Terms of Awards. 10 3.3.1 Committee Authority. 10 3.3.2 Forfeiture; Recoupment. 11 3.4 No Repricing Without Stockholder Approval. 12 3.5 Deferral Arrangement. 12 3.6 Registration; Share Certificates. 12 4. Stock Subject to the Plan 12 4.1 Number of Shares of Stock Available for Awards. 12 4.2 Adjustments in Authorized Shares of Stock. 13 4.3 Share Usage. 13 5. Term; Amendment and Termination 14 5.1 Term. 14 5.2 Amendment, Suspension, and Termination. 14 6. Award Eligibility and Limitations 14 6.1 Eligible Grantees. 14 6.2 Stand-Alone, Additional, Tandem, and Substitute Awards. 14 7. Award Agreement 15 8. Terms and Conditions of Options 15 8.1 Option Price. 15 8.2 Vesting and Exercisability. 15 8.3 Term. 15 8.4 Termination of Service. 16 8.5 Limitations on Exercise of Option. 16 8.6 Method of Exercise. 16 8.7 Rights of Holders of Options. 16 8.8 Delivery of Stock. 16 8.9 Transferability of Options. 16 8.10 Family Transfers. 17
12/34/56
EX-10.7
from 8-K 4 pages Assignment and Assumption Agreement
12/34/56
EX-10.6
from 8-K 9 pages Non-Competition and Non-Solicitation Agreement
12/34/56
EX-10.5
from 8-K 14 pages Lock-Up Agreement
12/34/56
EX-10.4
from 8-K 31 pages Amended and Restated Registration Rights Agreement
12/34/56
EX-10.17
from S-4/A 44 pages Lease Agreement Between Mitsui Sumitomo Insurance Company of America (Landlord) -And- Tevogen Bio Inc
12/34/56
EX-10.16
from S-4/A 35 pages The Wanamaker Building Office Lease Agreement by and Between Wanamaker Office Lease, LP a Delaware Limited Partnership (“Landlord”) and Tevogen Bio Inc a Delaware Corporation (“Tenant”) Dated June 9, 2022 I Office Lease Agreement Between Wanamaker Office Lease, LP, Landlord and Tevogen Bio Inc, Tenant
12/34/56